What is the difference between Mvasi and Avastin?
Mvasi (bevacizumab-awwb) is a biosimilar to Avastin (bevacizumab).
Mvasi is not interchangeable with Avastin. The prescriber must write a prescription specifically for Mvasi.
A biosimilar, according to the FDA, is a biological product that is highly similar to an FDA-approved biological product, known as a reference product (in this case Avastin), and has no clinically meaningful differences in terms of safety and effectiveness.
See Biosimilar and Interchangeable Biologics: More Treatment Choices
Mvasi has the same approved indications as Avastin, with the exception of hepatocellular carcinoma.
Avastin | Mvasi | |
---|---|---|
Generic Name | bevacizumab | bevacizumab-awwb |
How Supplied |
|
|
Indications |
|
|
Mvasi was approved in 2017 as the first biosimilar to Avastin. A second Avastin biosimilar called Zirabev (bevacizumab-bvzr) was approved in 2019, and a third called Alymsys (bevacizumab-maly) was approved in 2022.
Related questions
Read next
What are anti-VEGF drugs (VEGF inhibitors)?
Anti-VEGF drugs slow the abnormal growth of blood vessels associated with certain cancers and degenerative eye conditions, such as age-related macular degeneration. Anti-VEGF stands for anti-vascular endothelial growth factor. Continue reading
How often should I have a colonoscopy with ulcerative colitis?
If you have ulcerative colitis (UC), and you have had it for at least 8 years, then you should have a colonoscopy every 1 to 2 years. This is because people with UC have an increased risk of colorectal cancer. Continue reading
What is the success rate of Keytruda?
In general, PD-1 immune checkpoint inhibitors like Keytruda have been shown to significantly prolong overall survival (OS) in some patients with various cancer types, but Keytruda does not always work for everyone. Continue reading
Related medical questions
- What are biologic drugs and how do they work?
- What biosimilars have been approved in the United States?
- How long does it take for Keytruda to work?
- Why do you need to take Xeloda with food?
- Pembrolizumab vs. nivolumab: How do they compare?
- How long does oxaliplatin stay in your system?
- How many cycles of oxaliplatin can you have?
- How effective is Lumakras, what's the survival rate?
- How long does Lonsurf increase survival in colorectal cancer?
- Opdivo vs Opdivo Qvantig: What is the Difference?
- How effective are Opdivo and Yervoy when taken together?
- How effective is tucatinib (Tukysa) for breast cancer?
- What's the mechanism of action for tucatinib?
- What is Braftovi used to treat?
- Common Types of Cancer Medications
- Is small cell or non-small cell lung cancer worse?
- Is non-small cell lung cancer hereditary?
- How aggressive is non-small cell lung cancer?
- Does smoking cause non-small cell lung cancer?
- What type of lung cancer is Vizimpro used to treat?
- What type of cancer is Tecentriq used to treat?
- Why give Taxol (Paxel) before carboplatin?
- What is the difference between Opdivo and Keytruda?
- What is Paxel called in the USA?
- How effective is Tabrecta?
- Are there cost-saving programs for Tecentriq?
- How does erlotinib work (mechanism of action)?
- How long can I take Gilotrif (afatinib) for?
- How effective is atezolizumab (Tecentriq)?
- Is atezolizumab (Tecentriq) a chemotherapy or immunotherapy drug?
Drug information
Related support groups
- Avastin (9 questions, 46 members)
- Bevacizumab (4 questions, 7 members)
- Mvasi (3 questions, 5 members)
- Colorectal Cancer (19 questions, 53 members)
- Non-Small Cell Lung Cancer (53 questions, 70 members)
- Renal Cell Carcinoma (32 questions, 103 members)
- Cervical Cancer (6 questions, 25 members)
- Glioblastoma Multiforme (1 questions, 27 members)